Publications
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primates;
Pons-Faudoa, FP, Di Trani, N, Capuani, S, Hernandez, N, Wood, AM, Nehete, B, Niles, J, Shelton, KA, Kezar, S, Bushman, LR, Chua, CYX, Ittmann, MM, Anderson, PL, Nehete, PN, Arduino, RC, Nichols, J & Grattoni, A 2023, , Journal of Controlled Release, vol. 358, pp. 116-127. https://doi.org/10.1016/j.jconrel.2023.04.037
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer;
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2023, , Clinical and Translational Radiation Oncology, vol. 39, 100592. https://doi.org/10.1016/j.ctro.2023.100592
Neoadjuvant versus definitive chemoradiation in locally advanced esophageal cancer for patients of advanced age or significant comorbidities;
Jensen, GL, Hammonds, KP & Haque, W 2023, , Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, vol. 36, no. 2. https://doi.org/10.1093/dote/doac050
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry;
Burns, EA, Sanchez, CG, Mathur, S, Guerrero, C, Muhsen, IN, Sarfraz, H, Hu, CCA, Tang, CHA, Shah, SS, Tremont, IW, Teh, B, Ganguly, S & Pingali, SRK 2023, , Annals of Hematology, vol. 102, no. 5, pp. 1111-1120. https://doi.org/10.1007/s00277-023-05140-6
Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer;
Liu, HC, Davila Gonzalez, D, Viswanath, DI, Vander Pol, RS, Saunders, SZ, Di Trani, N, Xu, Y, Zheng, J, Chen, SH, Chua, CYX & Grattoni, A 2023, , Advanced Science, vol. 10, no. 9, 2206873. https://doi.org/10.1002/advs.202206873
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats;
Paez-Mayorga, J, Campa-Carranza, JN, Capuani, S, Hernandez, N, Liu, H-C, Chua, CYX, Pons-Faudoa, FP, Malgir, G, Alvarez, B, Niles, JA, Argueta, LB, Shelton, KA, Kezar, S, Nehete, PN, Berman, DM, Willman, MA, Li, XC, Ricordi, C, Nichols, JE, Gaber, AO, Kenyon, NS & Grattoni, A 2022, , Nature Communications, vol. 13, no. 1, pp. 7951. https://doi.org/10.1038/s41467-022-35629-z
Emerging immunomodulatory strategies for cell therapeutics;
Chua, CYX, Jiang, AY, Eufrásio-da-Silva, T, Dolatshahi-Pirouz, A, Langer, R, Orive, G & Grattoni, A 2022, , Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2022.11.008
Localization of drug biodistribution in a 3D-bioengineered subcutaneous neovascularized microenvironment;
Capuani, S, Hernandez, N, Paez-Mayorga, J, Dogra, P, Wang, Z, Cristini, V, Chua, CYX, Nichols, JE & Grattoni, A 2022, , Materials Today Bio, vol. 16, 100390. https://doi.org/10.1016/j.mtbio.2022.100390
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney);
Siva, S, Ali, M, Correa, RJM, Muacevic, A, Ponsky, L, Ellis, RJ, Lo, SS, Onishi, H, Swaminath, A, McLaughlin, M, Morgan, SC, Cury, FL, Teh, BS, Mahadevan, A, Kaplan, ID, Chu, W, Grubb, W, Hannan, R, Staehler, M, Warner, A & Louie, AV 2022, , The Lancet Oncology, vol. 23, no. 12, pp. 1508-1516. https://doi.org/10.1016/S1470-2045(22)00656-8
Localization of drug biodistribution in a 3D-bioengineered subcutaneous neovascularized microenvironment;
Capuani, S, Hernandez, N, Paez-Mayorga, J, Dogra, P, Wang, Z, Cristini, V, Chua, CYX, Nichols, JE & Grattoni, A 2022, , Materials Today Bio, vol. 16, pp. 100390. https://doi.org/10.1016/j.mtbio.2022.100390